Monitoring therapeutic treatments against Burkholderia infections using imaging techniques

Tiffany M. Mott, R. Katie Johnston, Sudhamathi Vijayakumar, D. Mark Estes, Massoud Motamedi, Elena Sbrana, Janice Endsley, Alfredo Torres

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Burkholderia mallei, the etiologic agent of glanders, are Category B select agents with biothreat potential, and yet effective therapeutic treatments are lacking. In this study, we showed that CpG administration increased survival, demonstrating protection in the murine glanders model. Bacterial recovery from infected lungs, liver and spleen was significantly reduced in CpG-treated animals as compared with non-treated mice. Reciprocally, lungs of CpG-treated infected animals were infiltrated with higher levels of neutrophils and inflammatory monocytes, as compared to control animals. Employing the B. mallei bioluminescent strain CSM001 and the Neutrophil-Specific Fluorescent Imaging Agent, bacterial dissemination and neutrophil trafficking were monitored in real-time using multimodal in vivo whole body imaging techniques. CpG-treatment increased recruitment of neutrophils to the lungs and reduced bioluminescent bacteria, correlating with decreased bacterial burden and increased protection against acute murine glanders. Our results indicate that protection of CpG-treated animals was associated with recruitment of neutrophils prior to infection and demonstrated, for the first time, simultaneous real time in vivo imaging of neutrophils and bacteria. This study provides experimental evidencesupporting the importance of incorporating optimized in vivo imaging methods to monitor disease progression and to evaluate the efficacy of therapeutic treatment during bacterial infections.

Original languageEnglish (US)
Pages (from-to)383-401
Number of pages19
JournalPathogens
Volume2
Issue number2
DOIs
StatePublished - May 23 2013

Fingerprint

Burkholderia Infections
Glanders
Burkholderia mallei
Neutrophils
Neutrophil Infiltration
Lung
Bacteria
Whole Body Imaging
Therapeutics
Fluorescent Dyes
Bacterial Infections
Disease Progression
Monocytes
Spleen
Liver
Infection

Keywords

  • Burkholderia mallei
  • Cpg
  • Immunomodulation
  • In vivo imaging
  • Infrared fluorescent imaging

ASJC Scopus subject areas

  • Immunology and Microbiology(all)
  • Infectious Diseases
  • Microbiology (medical)
  • Immunology and Allergy
  • Molecular Biology

Cite this

Monitoring therapeutic treatments against Burkholderia infections using imaging techniques. / Mott, Tiffany M.; Johnston, R. Katie; Vijayakumar, Sudhamathi; Estes, D. Mark; Motamedi, Massoud; Sbrana, Elena; Endsley, Janice; Torres, Alfredo.

In: Pathogens, Vol. 2, No. 2, 23.05.2013, p. 383-401.

Research output: Contribution to journalArticle

Mott, Tiffany M. ; Johnston, R. Katie ; Vijayakumar, Sudhamathi ; Estes, D. Mark ; Motamedi, Massoud ; Sbrana, Elena ; Endsley, Janice ; Torres, Alfredo. / Monitoring therapeutic treatments against Burkholderia infections using imaging techniques. In: Pathogens. 2013 ; Vol. 2, No. 2. pp. 383-401.
@article{9fabf40a5066428f8cfddc37380f29d4,
title = "Monitoring therapeutic treatments against Burkholderia infections using imaging techniques",
abstract = "Burkholderia mallei, the etiologic agent of glanders, are Category B select agents with biothreat potential, and yet effective therapeutic treatments are lacking. In this study, we showed that CpG administration increased survival, demonstrating protection in the murine glanders model. Bacterial recovery from infected lungs, liver and spleen was significantly reduced in CpG-treated animals as compared with non-treated mice. Reciprocally, lungs of CpG-treated infected animals were infiltrated with higher levels of neutrophils and inflammatory monocytes, as compared to control animals. Employing the B. mallei bioluminescent strain CSM001 and the Neutrophil-Specific Fluorescent Imaging Agent, bacterial dissemination and neutrophil trafficking were monitored in real-time using multimodal in vivo whole body imaging techniques. CpG-treatment increased recruitment of neutrophils to the lungs and reduced bioluminescent bacteria, correlating with decreased bacterial burden and increased protection against acute murine glanders. Our results indicate that protection of CpG-treated animals was associated with recruitment of neutrophils prior to infection and demonstrated, for the first time, simultaneous real time in vivo imaging of neutrophils and bacteria. This study provides experimental evidencesupporting the importance of incorporating optimized in vivo imaging methods to monitor disease progression and to evaluate the efficacy of therapeutic treatment during bacterial infections.",
keywords = "Burkholderia mallei, Cpg, Immunomodulation, In vivo imaging, Infrared fluorescent imaging",
author = "Mott, {Tiffany M.} and Johnston, {R. Katie} and Sudhamathi Vijayakumar and Estes, {D. Mark} and Massoud Motamedi and Elena Sbrana and Janice Endsley and Alfredo Torres",
year = "2013",
month = "5",
day = "23",
doi = "10.3390/pathogens2020383",
language = "English (US)",
volume = "2",
pages = "383--401",
journal = "Pathogens",
issn = "2076-0817",
publisher = "MDPI AG",
number = "2",

}

TY - JOUR

T1 - Monitoring therapeutic treatments against Burkholderia infections using imaging techniques

AU - Mott, Tiffany M.

AU - Johnston, R. Katie

AU - Vijayakumar, Sudhamathi

AU - Estes, D. Mark

AU - Motamedi, Massoud

AU - Sbrana, Elena

AU - Endsley, Janice

AU - Torres, Alfredo

PY - 2013/5/23

Y1 - 2013/5/23

N2 - Burkholderia mallei, the etiologic agent of glanders, are Category B select agents with biothreat potential, and yet effective therapeutic treatments are lacking. In this study, we showed that CpG administration increased survival, demonstrating protection in the murine glanders model. Bacterial recovery from infected lungs, liver and spleen was significantly reduced in CpG-treated animals as compared with non-treated mice. Reciprocally, lungs of CpG-treated infected animals were infiltrated with higher levels of neutrophils and inflammatory monocytes, as compared to control animals. Employing the B. mallei bioluminescent strain CSM001 and the Neutrophil-Specific Fluorescent Imaging Agent, bacterial dissemination and neutrophil trafficking were monitored in real-time using multimodal in vivo whole body imaging techniques. CpG-treatment increased recruitment of neutrophils to the lungs and reduced bioluminescent bacteria, correlating with decreased bacterial burden and increased protection against acute murine glanders. Our results indicate that protection of CpG-treated animals was associated with recruitment of neutrophils prior to infection and demonstrated, for the first time, simultaneous real time in vivo imaging of neutrophils and bacteria. This study provides experimental evidencesupporting the importance of incorporating optimized in vivo imaging methods to monitor disease progression and to evaluate the efficacy of therapeutic treatment during bacterial infections.

AB - Burkholderia mallei, the etiologic agent of glanders, are Category B select agents with biothreat potential, and yet effective therapeutic treatments are lacking. In this study, we showed that CpG administration increased survival, demonstrating protection in the murine glanders model. Bacterial recovery from infected lungs, liver and spleen was significantly reduced in CpG-treated animals as compared with non-treated mice. Reciprocally, lungs of CpG-treated infected animals were infiltrated with higher levels of neutrophils and inflammatory monocytes, as compared to control animals. Employing the B. mallei bioluminescent strain CSM001 and the Neutrophil-Specific Fluorescent Imaging Agent, bacterial dissemination and neutrophil trafficking were monitored in real-time using multimodal in vivo whole body imaging techniques. CpG-treatment increased recruitment of neutrophils to the lungs and reduced bioluminescent bacteria, correlating with decreased bacterial burden and increased protection against acute murine glanders. Our results indicate that protection of CpG-treated animals was associated with recruitment of neutrophils prior to infection and demonstrated, for the first time, simultaneous real time in vivo imaging of neutrophils and bacteria. This study provides experimental evidencesupporting the importance of incorporating optimized in vivo imaging methods to monitor disease progression and to evaluate the efficacy of therapeutic treatment during bacterial infections.

KW - Burkholderia mallei

KW - Cpg

KW - Immunomodulation

KW - In vivo imaging

KW - Infrared fluorescent imaging

UR - http://www.scopus.com/inward/record.url?scp=85015512510&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015512510&partnerID=8YFLogxK

U2 - 10.3390/pathogens2020383

DO - 10.3390/pathogens2020383

M3 - Article

AN - SCOPUS:85015512510

VL - 2

SP - 383

EP - 401

JO - Pathogens

JF - Pathogens

SN - 2076-0817

IS - 2

ER -